ライフサイエンスコーパス: subclassification

1 pes and the therapeutic implications of this subclassification.

2 sult in a valuable second opinion and expert subclassification.

3 t retains as a major category the historical subclassification.

4 dings improves prognostication over the 1997 subclassification.

5 erity but does not function well in stenosis subclassification.

6 ffuse LPHD, and six had LP histology without subclassification.

7 lyses were performed on the 1992 and 1997 T2 subclassifications.

8 or germinal center B-cell-like (GCB)/non-GCB subclassification according to the Hans algorithm.

9 A subclassification among the various natural products of

10 obtained with EBUS-TBNA are suitable for the subclassification and genotyping of NSCLC.

11 cular features, and underpin current disease subclassification and initial subgroup-directed therapie

12 ne expression profiling has proven useful in subclassification and outcome prognostication for human

13 ether these could be used to improve disease subclassification and prognosis predictions.

14 They also serve as biomarkers for tumour subclassification and targets for hormone therapy.

15 receptor (AChR) antibody concentration, IgG subclassification, and C9 deposition at the neuromuscula

16 Autoantibody concentration, subclassification, and specificity were analyzed to addr

17 variability in prospective, molecular tumor subclassification associated with this effect.

18 ce-activated cell sorting allowed additional subclassification based on memBc/plasmablast function.

19 suggest leptin receptors may be divided into subclassifications based on pH sensitivity of the specif

20 GATA factor identity and provides a further subclassification criterion for this transcription facto

21 tages I through IV, tumor size category, and subclassification (defined by the presence of ciliary bo

22 These results suggest that 1992 T2 subclassification derived from palpable findings improve

23 of IIMs do not fit well into the typical IIM subclassifications: dermatomyositis, polymyositis and in

24 , in the 2008 WHO classification scheme, FAB subclassification does not provide prognostic informatio

25 This molecular subclassification has implicated several biological proc

26 he method's impact on calculated DPD, PH-LHD subclassification, hemodynamic profiles, and mortality.

27 plications of cirrhosis, on the basis of the subclassification in clinical stages.

28 Genetic definition has allowed subclassification into translated polyglutamine diseases

29 Molecularly defined subclassification is associated with phenotypic malignan

30 hese tumours, based on accurate histological subclassification, merit wider recognition.

31 Prospective testing of the subclassification method corroborated these findings.

32 ation in treatment responses associated with subclassification of achalasia, the use of distal latenc

33 For most of the 20th century, subclassification of acute myeloid leukemia (AML) was ba

34 e gene expression patterns made possible the subclassification of adenocarcinoma into subgroups that

35 The new World Health Organization (WHO) subclassification of AML includes elements of this new p

36 ased on the resistance signature enabled the subclassification of an independent, validation cohort o

37 this study we sought to determined whether a subclassification of CN according to vascular pathology

38 iopsies and contributes to the diagnosis and subclassification of cutaneous lymphoid lesions.

39 tion entrance width (FW) and height (FH) and subclassification of defects according to vertical bone

40 therapy, the prognostic significance of this subclassification of DLBCL is unclear.

41 retrospective study, we have shown that the subclassification of DLBCL on the basis of the cell of o

42 These data further validate the RDP-based subclassification of GBS and suggest that lineage-specif

43 Subclassification of high labeling score (>/=40) for Cdc

44 The subclassification of immunology into innate and adaptive

45 ted as "marginal zone B-cell" lymphomas; the subclassification of large B-cell lymphomas; and the com

46 p has also proposed modifications of the FAB subclassification of MDS.

47 the first major insights into the molecular subclassification of melanoma and the heterogeneous natu

48 Subclassification of melanoma by NSLN tumor status shoul

49 large number of patients may lead to better subclassification of not only LGL but also other immune-

50 ar genetic correlates of a recently proposed subclassification of papillary renal cell carcinoma (PRC

51 clinical relevance of gene expression-based subclassification of pediatric septic shock.

52 unostaining for OX40/CD134 may be helpful in subclassification of peripheral T-cell lymphomas and tha

53 ated with Abeta amyloidosis, suggesting that subclassification of PPA based on language features can

54 alidates the prognostic relevance of the WHO subclassification of SM and provides additional informat

55 e EBS declined by 76.7% as a result of later subclassification of some of those patients into other s

56 work was dependent upon or influenced by the subclassification of some T-cell malignancies as ATL (in

57 Subclassification of submucosal invasion showed that 5 o

58 provided evidence that HTLV-1 caused ATL, a subclassification of T-cell malignancies first recognize

59 rsity, providing a rationale for a molecular subclassification of the disease.

60 ytometry on 15 specimens, and contributed to subclassification of the lymphomas.

61 posity with low muscle mass, and HA-LM-and a subclassification of the phenotypes into classes I, II,

62 RNA synthetase, which led us to define a new subclassification of these ancient enzymes and to propos

63 diagnosis of CTCL as well as more consistent subclassification of these entities.

64 Criteria for diagnosis and subclassification of these lesions include peripheral bl

65 e objective immunohistochemical criteria for subclassification of these tumors.

66 ammation (i-t) meeting TCMR criteria allowed subclassification of v-lesion specimens into 21 i-t-v-le

67 nalyses lend support to the previous overall subclassification of vertebrate genes, but suggest that

68 Within this family are two subclassifications of proteins, based on primary sequenc

69 dependent variations of R values and uncover subclassifications of these species.

70 1992 (P =.005) but not the 1997 (P =.100) T2 subclassification predicted outcome after controlling fo

71 as biomarker for differential diagnosis and subclassification rather than predictor of response to t

72 We also propose a subclassification scheme for miRNAs for assisting future

73 olecular classification and further suggests subclassification schemes.

74 sensitivity, 53.8%; specificity, 89.5%), SSN subclassification (sensitivity, 81.5%; specificity, 88.2

75 SSN subclassification showed a significant linear trend with

76 alues, and negative predictive values of the subclassification strategy were >/= 4% across the three

77 known about iMCD pathogenesis, present a new subclassification system, and propose a model of iMCD pa

78 Superimposed on this framework are subclassifications that are based on topology of the mal

79 e through the tool HiBS (Heterogeneity-Based Subclassification) that allows cancer sample classificat

80 After subclassification, the clinical database was mined for p

81 dings could have implications for additional subclassification to supplement prediction of the achala

82 th lymphoma as a final diagnosis, histologic subclassification was sufficient to guide treatment with

83 ate analysis of node-negative patients, this subclassification was the only predictor for distant rec

84 Subclassifications were significantly associated with in

85 cular complexity of TNBC has led to proposed subclassifications, which will be of great value for the

86 ies, but is limited when applied to detailed subclassification within these families.

87 Utilizing these subclassifications would likely strengthen future prospe